Company Filing History:
6 out of 1,504 
1 out of 3 
1 out of 1 Years Active: 2019-2023
Title: The Innovative Contributions of Peter Brauer
Introduction
Peter Brauer is a notable inventor based in Singapore, SG. He has made significant contributions to the field of biotechnology, holding a total of 7 patents. His work primarily focuses on developing antigen-binding molecules that have potential applications in therapeutic settings.
Latest Patents
Among his latest patents are the IL2Rbeta/common gamma chain antibodies. These antigen-binding molecules are capable of binding to CD122 and/or the common gamma chain (CD132). The patent also discloses compositions comprising such antigen-binding molecules, along with various uses and methods utilizing them. Another significant patent involves CD47 antigen-binding molecules, which are also disclosed in his work. This includes nucleic acids and expression vectors encoding these molecules, as well as compositions and methods for their use.
Career Highlights
Peter has worked with prominent organizations such as the Agency for Science, Technology and Research and Hummingbird Bioscience Pte. Ltd. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Throughout his career, Peter has collaborated with esteemed colleagues, including Siok Ping Yeo and John Edward Connolly. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Peter Brauer's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence advancements in therapeutic applications.